SlideShare uma empresa Scribd logo
1 de 20
Baixar para ler offline
Speeding up media design: a novel high
throughput approach for rapid cell culture
media development
Cell Culture World Congress 2013, Munich, 26 February 2013

Authors: Arnaud Périlleux, Yolande Rouiller, Martin Jordan and Matthieu Stettler
Biotech Process Sciences, Upstream Development Group
Merck Serono S.A. Vevey, Switzerland
Merck Serono at a glance
 Merck Serono SA is the largest division
of Merck KGaA
– Established in January 2007,17’000 employees,
EUR 5.9 billion in 2011, headquarter in
Darmstadt, Germany
– In the United States and Canada, Merck Serono
operates under the name of EMD Serono (a
separately incorporated affiliate of Merck Serono)

 Merck Serono SA process development
and production site in Vevey,
Switzerland
– One of the largest and most technologically
advanced biotech centers in the world (4 x 5K and
8 x 15K production capacity)
– Production of Rebif® (INF beta-1a) since 1999
– Production of Erbitux® (Cetuximab) since 2011
Merck Serono’s headquarter in Darmstadt (top) and
development and production site in Vevey (bottom)
2

Cell Culture World Congress | 26 February 2013
Presentation scope
 Overview of Merck Serono’s high throughput cell culture methods
 Case study #1: High throughput media blending
– How to obtain a new high performance medium in one single experiment?

 Case study #2: Product quality optimization
– How are quality analyses possible with micro-scale culture systems?

 Perspectives
– Strategies to quickly develop processes with strong quality requirements

3

Cell Culture World Congress | 26 February 2013
Merck Serono’s HT cell culture methods
Overview
Integrated development approach
Cell line evaluation

Predictive, scalable and comprehensive set of tools
High throughput cell culture methods
for fed-batch processes assessing
24 to 400+ cultures in parallel

Medium development

High performance
cell lines

Media Blending
Feed Blending
DoE

Feed development

High performance
processes

CFD
Process development

Process validation
Quality by Design

4

Cell Culture World Congress | 26 February 2013

Deliver the right
product quality
Merck Serono’s HT cell culture methods
High throughput evaluation of cell lines in fed-batch

Transfection and selection

A

B

C

D

Cloning in static 384 well plate
Adaptation in shaking 96DWP

A
Fed-batch in shaking 96DWP

Up to 500
clonal cell
lines

0.5 mL
0.5 mL
10 mL

Scale up to shake tubes

B
Fed-batch in shake tubes

C

5

Fed-batch in lab-scale bioreactors

Cell Culture World Congress | 26 February 2013

30 mL
15 mL

Fed-batch in micro-scale bioreactors

D

12 cell lines

4 candidate
cell lines

3 000 mL
Case study #1: High throughput media blending

A high-throughput media design approach for high
performance mammalian fed-batch cultures
Authors:
Yolande Rouiller, Arnaud Périlleux, Natacha Collet,
Martin Jordan, Matthieu Stettler, Hervé Broly
Manuscript accepted, to be published in mAbs
Case study #1: High throughput media blending
Workflow
47 components

16 media formulations
varying 43 out of 47 components

Blends automatically
mixed in 96DWP

Predicted vs. Actual

3 passages prior
a 14-days fed-batch

Titer (mg/L)

Data
analysis

376 media
blends tested

3000
2000
1000
0
0 2 4 6 8 101214
Elapsed time (days)

7

Cell Culture World Congress | 26 February 2013

Data
acquisition
Case study #1: High throughput media blending
 Protocol
– 3 passages prior fed-batch inoculation, an
antibody expressing cell line is diluted in
each of the 376 blends
• Guaranty to obtain a medium suitable for both
expansion and fed-batch process

Viable Cell Density
(x106 cells/mL)

Evaluation of 376 media blends

– Performance assessment

8

Cell Culture World Congress | 26 February 2013

20
15
10

Titer (mg/L)

2

4

6

8 10 12 14

2

4

6

8 10 12 14

2500
2000
1500
1000
500

• Cell count, Cell viability with a Guava Easycyte
• Titer quantification with an Octet

Fed-batch process

0
-6
3500 -8Ctrl 1-4 -2 0
3000 Ctrl 2

• Standardized and controlled experimental
setup

• Guaranty to obtain a medium adapted to the
feed system

Cell expansion
3 passages

5

– Each of the 376 cultures is diluted individually
targeting a specific cell density

– On day 2, 4, 7 and 10, a reference proprietary
feed is added

25

KQe

0
-8 -6 -4 -2 0

Time (days)
Case study #1: High throughput media blending
Data analysis opportunities

Data analysis using three approaches
1st approach: Excel spreadsheet
Ranking of various tested
conditions

Identification of key media
formulations

Identification of key components

Selection of promising
formulations

9

2nd approach: DoE (Design
Expert)

Design of predicted best
formulation

List of key components to be
further optimized

Cell Culture World Congress | 26 February 2013

3rd approach: MVA (Simca P++)
Case study #1: High throughput media blending
Data analysis with Design of Experiment (DoE)
Titer at Day 14
Predicted values

 DoE analysis allows
– To identify the key formulations (out of the 16)
– To design new media formulations

 DoE analysis does not allow
– To understand why some media are better than others

3000
2000
1000

R2 = 0.88
Adj. R2 = 0.84
Pred. R2 = 0.76

0
0

10

Prediction 1
Prediction 4

Prediction 2
Prediction 5

Predicted Values

Prediction 3
Average

Prediction PDL

F16

F15

F14

F13

F12

F11

F10

F9

F8

F7

F6

F5

10.47 238

3933

10.42 226

3908

10.45 230

3902

5th
F4

3960

4th
F3

10.43 226

3rd

F2

Titer

2nd

Cell Culture World Congress | 26 February 2013

IVC

1st

35%
30%
25%
20%
15%
10%
5%
0%
F1

% of each formulation
in the predicted medium

Compositions of best predicted media based on the 16 formulations

1000 2000 3000
Observed values

10.39 224

3885

Average

10.43 228

3910
Case study #1: High throughput media blending
Data analysis with MultiVariate Analysis (MVA)
 MVA analysis allows
– To rank the 43 components in terms of influence on performance
– To identify the key components that could be interesting for further optimization (in orange and yellow)

 MVA analysis does not allow
– To have a strong confidence in the conclusions due to the relatively low number of conditions
tested compared to the high number of factors evaluated

Components with strong influence in MVA
Components that correlate by design with key components

11

Cell Culture World Congress | 26 February 2013

Titer Day 14 (mg/L)

0.4
0.3
0.2
0.1
0
-0.1
-0.2
-0.3

L-Serine
D-Biotin
L-Arginine
Thymidine
L-Aspartic acid
L-Leucine
L-Glutamic acid
Hypoxanthine
Zinc Sulfate
myo-Inositol
NaH2PO4
L-Histidine
Sodium Selenite
Putrescine
L-Tyrosine
Riboflavin
Choline Chloride
Pyridoxine
L-Lysine x HCl
L-Phenylalanine
L-Isoleucine
Calcium Chloride
Folic acid
Vitamin B12
Thiamine
Pluronic
Ethanolamine
L-Aspargine
Cupric sulfate
L-Cysteine
Niacinamide (B3)
Glycine
L-Threonine
L-Tryptophan
L-Proline
Magnesium Sulfate
L-Alanine
L-Methionine
Sodium pyruvate
Potassium Chloride
L-Valine
D-Pantothenic acid x 1/2Ca
Ferric ammonium citrate

Coefficients scaled & centered
(components 1 to 3 of PLS model)

Influence of increased levels of the tested components in the PLS regression of titers at day 14

Ferric Ammonium Citrate (mg/L)
Case study #1: High throughput media blending
Scale-up, confirmation and conclusions
Reference New
medium medium
Cell line 1
Cell line 2
Cell line 3

 8 media from the ranking approach and 1
from the DoE approach were scaled up in
shake tubes
 1 medium was selected for scale up in
bioreactor and evaluated on several cell lines
– The 3 cell lines showed from 30 to 60% titer
improvement

Titer (mg/L)

– data not shown

6000
5000
4000
3000
2000
1000
0

 Conclusions

0

2

4

6 8 10 12 14 16 18
Time (days)

– Media blending allows in one single experiment to identify new media formulations with high
potential for performance improvement
– Same approach can be made with feeds
– An approach combining medium and feed blending can be designed
12

Cell Culture World Congress | 26 February 2013
Case study #2: Product quality optimization
using high-throughput cell culture methods
Case study #2: Product quality optimization
Are quality analyses possible with micro-scale cultures?
 Context
– Cell culture process development required to optimize a large number
of critical quality attributes (CQAs)
• Isoforms (deamidation, oxydation, …), glycoforms, (galactosylation,
mannosylation, fucosylation, sialylation), product integrity, process
impurities
– Most of the CQAs are linked to the recombinant cell line, the medium
and feeds, and the process (physical parameters)
– To ensure a successful process development (e.g. next generation
process), it is important that the new process provides a product with
the same quality

14

Cell Culture World Congress | 26 February 2013
Case study #2: Product quality optimization
Are quality analyses possible with micro-scale cultures?
 Challenges
– High throughput cell culture methods (i.e.
96DWP) provide small amounts of product

Fed batch process in
96DWP

400-500 µL
225-1500 µg

– Analytical lab should be able to analyze 400+
samples with 5+ analytical methods
• Capture, glycan analysis, charge profile,
integrity, …

 Achievements
– A combination of media blending and DoE
generated 400 samples of about 400 µL

Capture on Phytips®

Charge profile
iCE280
Glycan analysis
CGE-LIF

– Samples were captured using Phytips®
– Samples were analyzed in 2.5 weeks on 5
analytical methods
– 8800 results were generated

15

Cell Culture World Congress | 26 February 2013

Integrity
SE-HPLC
Caliper NR
Case study #2: Product quality optimization
Experiment design
Factors tested in DoE

 Combine media blending and DoE design

Zn

N-acetylcystein

Cu

pH  HCl

Fe

NaCl

Se

NaButyrate

Mn

Hydrocortisone

Galactose

Spermine
Ascorbic acid + Retinol
+ 4-aminobenzoic acid
+ a-tocopherol
Lipids

– 5 new Basal Media (BM) mixed to obtain 11 media
– 17 factors tested in DoE by addition on day 5
– Standard platform feeding strategy
– Analytics performed on day 14
• Biacore
• CGE-LIF, iCE280
• Caliper NR, SE HPLC

Fucose
Uridine
ManNAc

Additional factors
2ndary feed
Main Feed
Glucose

0
16

Cell Culture World Congress | 26 February 2013

3

5

7

10

14
Case study #2: Product quality optimization
Results

– After optimization, the confirmation and
scale up of a new manufacturing process
version was performed
17

Cell Culture World Congress | 26 February 2013

Model: R2 = 74.9% / R2 adj. = 71.2%

BM4

• to select 4 factors and 2 media for further
optimization

32 DoE conditions

Mix1

• to fix the levels of 4 factors

1.0
0.8
0.6
0.4
0.2
0.0
-0.2
-0.4
-0.6

Spermine

– Models allow

Std. Coef. (Cluster 4)

– For most of the CQAs, at least some
conditions were able to match the TPP

Control (n=4)

BM3

 Conclusions

Mix5

10

Mix4

– Lists of key media and factors were
established from models

15

NaCl

– Models were defined

20

All data
BM1
BM2
BM3
BM4
BM5
Mix1
Mix2
Mix3
Mix4
Mix5
Mix6
BM1
BM2
BM3
BM4
BM5

– Distribution of results was compared to
Target Product Profile (TPP)

25

Cu

 For each CQA

Charge Profile
Cluster 4 (%)

30
HT cell culture – Speeding up media design
Conclusions
 High throughput tools are now available for cell culture, but also
for purification and analytics
 Designing the right experiments allows to get the maximum of
these tools and to reduce development timelines
 Their use has been mainly directed to media design, but their
application to feed design could even provide more interesting
results

18

Cell Culture World Congress | 26 February 2013
Acknowledgements
 Biotech Process Sciences
(BPS), Merck Serono SA
Vevey, Switzerland
– Hervé Broly - Head of BPS
– Upstream Development Group
– Flavie Robert - Head of Analytical
Group

19

Cell Culture World Congress | 26 February 2013
Questions

20

Cell Culture World Congress | 26 February 2013

Mais conteúdo relacionado

Mais procurados

Moisture content determination by karl fischer titration
Moisture content determination by karl fischer titrationMoisture content determination by karl fischer titration
Moisture content determination by karl fischer titrationDaman Pandey
 
ICH Q2 Analytical Method Validation
ICH Q2  Analytical Method ValidationICH Q2  Analytical Method Validation
ICH Q2 Analytical Method ValidationNaila Kanwal
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...MilliporeSigma
 
Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle managementChandra Prakash Singh
 
Inprocess quality control tests for biological products
Inprocess quality control tests for biological productsInprocess quality control tests for biological products
Inprocess quality control tests for biological productsnishathfathima
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Merck Life Sciences
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004Patel Parth
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practicesrasika walunj
 
Druggability of NCEs
Druggability of NCEsDruggability of NCEs
Druggability of NCEsDheeraj Kumar
 
Ion Exchange Chromatography
Ion Exchange ChromatographyIon Exchange Chromatography
Ion Exchange ChromatographyVithya sekar
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization KBI Biopharma
 
Chromatographic Methods of Analysis ( Gel Chromatography Method )
Chromatographic Methods of Analysis ( Gel Chromatography Method )Chromatographic Methods of Analysis ( Gel Chromatography Method )
Chromatographic Methods of Analysis ( Gel Chromatography Method )FLI
 

Mais procurados (20)

Moisture content determination by karl fischer titration
Moisture content determination by karl fischer titrationMoisture content determination by karl fischer titration
Moisture content determination by karl fischer titration
 
ICH Q2 Analytical Method Validation
ICH Q2  Analytical Method ValidationICH Q2  Analytical Method Validation
ICH Q2 Analytical Method Validation
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
 
Bet ppt
Bet pptBet ppt
Bet ppt
 
Good lab practices (GLP)
Good lab practices (GLP)Good lab practices (GLP)
Good lab practices (GLP)
 
Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle management
 
Inprocess quality control tests for biological products
Inprocess quality control tests for biological productsInprocess quality control tests for biological products
Inprocess quality control tests for biological products
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
 
good laboratory practices
 good laboratory practices good laboratory practices
good laboratory practices
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
Autoclave validation maliba
Autoclave validation malibaAutoclave validation maliba
Autoclave validation maliba
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
 
Druggability of NCEs
Druggability of NCEsDruggability of NCEs
Druggability of NCEs
 
Ion Exchange Chromatography
Ion Exchange ChromatographyIon Exchange Chromatography
Ion Exchange Chromatography
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
Q2 r1 guidelines
Q2 r1 guidelinesQ2 r1 guidelines
Q2 r1 guidelines
 
Chromatographic Methods of Analysis ( Gel Chromatography Method )
Chromatographic Methods of Analysis ( Gel Chromatography Method )Chromatographic Methods of Analysis ( Gel Chromatography Method )
Chromatographic Methods of Analysis ( Gel Chromatography Method )
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
Antibody's in drug delivery
Antibody's in drug delivery Antibody's in drug delivery
Antibody's in drug delivery
 

Destaque

Development of novel chemically defined media for CHO cell applications
Development of novel chemically defined media for CHO cell applicationsDevelopment of novel chemically defined media for CHO cell applications
Development of novel chemically defined media for CHO cell applicationsNational Institute of Biologics
 
Integrated utilization of high-throughput bioreactors & high-throughput analy...
Integrated utilization of high-throughput bioreactors & high-throughput analy...Integrated utilization of high-throughput bioreactors & high-throughput analy...
Integrated utilization of high-throughput bioreactors & high-throughput analy...KBI Biopharma
 
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...fujifilmdiosynth
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...KBI Biopharma
 
The Application of Statistical Design of Experiments for Mathematical Modelin...
The Application of Statistical Design of Experiments for Mathematical Modelin...The Application of Statistical Design of Experiments for Mathematical Modelin...
The Application of Statistical Design of Experiments for Mathematical Modelin...realjimcarey
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...KBI Biopharma
 
Effect of raw materials and production processes on dry powder media quality
Effect of raw materials and production processes on dry powder media qualityEffect of raw materials and production processes on dry powder media quality
Effect of raw materials and production processes on dry powder media qualityNational Institute of Biologics
 
A practical approach to raw material sourcing and management in cell culture
A practical approach to raw material sourcing and management in cell cultureA practical approach to raw material sourcing and management in cell culture
A practical approach to raw material sourcing and management in cell cultureNational Institute of Biologics
 
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...Albert Paul
 
An Approach to High Cell Density Fed-batch Experiments
An Approach to High Cell Density Fed-batch ExperimentsAn Approach to High Cell Density Fed-batch Experiments
An Approach to High Cell Density Fed-batch Experimentsdelyanrusev
 
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...KBI Biopharma
 
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...KBI Biopharma
 
Key Components of Pharmaceutical QbD, an Introduction
Key Components of Pharmaceutical QbD, an IntroductionKey Components of Pharmaceutical QbD, an Introduction
Key Components of Pharmaceutical QbD, an IntroductionSaurabh Arora
 
Human insulin production process & requirement
Human insulin production process & requirementHuman insulin production process & requirement
Human insulin production process & requirementKrishnasalini Gunanathan
 

Destaque (20)

Development of a cutting edge CHO cell culture medium
Development of a cutting edge CHO cell culture mediumDevelopment of a cutting edge CHO cell culture medium
Development of a cutting edge CHO cell culture medium
 
Development of novel chemically defined media for CHO cell applications
Development of novel chemically defined media for CHO cell applicationsDevelopment of novel chemically defined media for CHO cell applications
Development of novel chemically defined media for CHO cell applications
 
Design Upstream
Design UpstreamDesign Upstream
Design Upstream
 
Organ & Organ System
Organ & Organ SystemOrgan & Organ System
Organ & Organ System
 
Integrated utilization of high-throughput bioreactors & high-throughput analy...
Integrated utilization of high-throughput bioreactors & high-throughput analy...Integrated utilization of high-throughput bioreactors & high-throughput analy...
Integrated utilization of high-throughput bioreactors & high-throughput analy...
 
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...
Reducing Timelines & Increasing Titres by Host Cell Lines with Improved Chara...
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
 
The Application of Statistical Design of Experiments for Mathematical Modelin...
The Application of Statistical Design of Experiments for Mathematical Modelin...The Application of Statistical Design of Experiments for Mathematical Modelin...
The Application of Statistical Design of Experiments for Mathematical Modelin...
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
 
Effect of raw materials and production processes on dry powder media quality
Effect of raw materials and production processes on dry powder media qualityEffect of raw materials and production processes on dry powder media quality
Effect of raw materials and production processes on dry powder media quality
 
Evaluation of antibody drugs quality safety
Evaluation of antibody drugs quality safetyEvaluation of antibody drugs quality safety
Evaluation of antibody drugs quality safety
 
A practical approach to raw material sourcing and management in cell culture
A practical approach to raw material sourcing and management in cell cultureA practical approach to raw material sourcing and management in cell culture
A practical approach to raw material sourcing and management in cell culture
 
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...
Oral presentation at ESACT 2015 (Barcelona) - Identification of process param...
 
An Approach to High Cell Density Fed-batch Experiments
An Approach to High Cell Density Fed-batch ExperimentsAn Approach to High Cell Density Fed-batch Experiments
An Approach to High Cell Density Fed-batch Experiments
 
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
 
BDDW Mar15
BDDW Mar15 BDDW Mar15
BDDW Mar15
 
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
 
Key Components of Pharmaceutical QbD, an Introduction
Key Components of Pharmaceutical QbD, an IntroductionKey Components of Pharmaceutical QbD, an Introduction
Key Components of Pharmaceutical QbD, an Introduction
 
Usp biotherapeutics - biological medicines
Usp  biotherapeutics - biological medicinesUsp  biotherapeutics - biological medicines
Usp biotherapeutics - biological medicines
 
Human insulin production process & requirement
Human insulin production process & requirementHuman insulin production process & requirement
Human insulin production process & requirement
 

Semelhante a Speeding up media design in cell culture - a novel high throughput approach for rapid cell culture media development

Metabolon Global Metabolomics
Metabolon Global MetabolomicsMetabolon Global Metabolomics
Metabolon Global MetabolomicsDave Maske
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationMilliporeSigma
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationMerck Life Sciences
 
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014Dairy Innovation Australia
 
The Bioprocessing Summit 2014 Agenda
The Bioprocessing Summit 2014 AgendaThe Bioprocessing Summit 2014 Agenda
The Bioprocessing Summit 2014 Agendanproulx
 
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentWebinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentBIS Research Inc.
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentationJoseph Zimmermann
 
Learn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigmaLearn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigmaMilliporeSigma
 
Compound Management Focus 2010
Compound Management Focus 2010Compound Management Focus 2010
Compound Management Focus 2010GWendelSGC
 
The Bioprocessing Summit 2015
The Bioprocessing Summit 2015The Bioprocessing Summit 2015
The Bioprocessing Summit 2015Nicole Proulx
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformMerck Life Sciences
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformMilliporeSigma
 
Explainable AI in Drug Hunting
Explainable AI in Drug HuntingExplainable AI in Drug Hunting
Explainable AI in Drug HuntingEd Griffen
 
Microalgas para la producción de biocombustibles, alimentos y productos químicos
Microalgas para la producción de biocombustibles, alimentos y productos químicosMicroalgas para la producción de biocombustibles, alimentos y productos químicos
Microalgas para la producción de biocombustibles, alimentos y productos químicosEOI Escuela de Organización Industrial
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...Medicines Discovery Catapult
 

Semelhante a Speeding up media design in cell culture - a novel high throughput approach for rapid cell culture media development (20)

Metabolon Global Metabolomics
Metabolon Global MetabolomicsMetabolon Global Metabolomics
Metabolon Global Metabolomics
 
Adrian_Joseph
Adrian_JosephAdrian_Joseph
Adrian_Joseph
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
 
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014
Post-farmgate Dairy Research in Australia - DIAA Vic Conf May 2014
 
The Bioprocessing Summit 2014 Agenda
The Bioprocessing Summit 2014 AgendaThe Bioprocessing Summit 2014 Agenda
The Bioprocessing Summit 2014 Agenda
 
CV_Mohammed Akhlaq
CV_Mohammed AkhlaqCV_Mohammed Akhlaq
CV_Mohammed Akhlaq
 
Delivering The Benefits of Chemical-Biological Integration in Computational T...
Delivering The Benefits of Chemical-Biological Integration in Computational T...Delivering The Benefits of Chemical-Biological Integration in Computational T...
Delivering The Benefits of Chemical-Biological Integration in Computational T...
 
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentWebinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
 
Learn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigmaLearn about the latest innovations at MilliporeSigma
Learn about the latest innovations at MilliporeSigma
 
FINAL
FINAL FINAL
FINAL
 
Mycenax Introduction_
Mycenax Introduction_Mycenax Introduction_
Mycenax Introduction_
 
Compound Management Focus 2010
Compound Management Focus 2010Compound Management Focus 2010
Compound Management Focus 2010
 
The Bioprocessing Summit 2015
The Bioprocessing Summit 2015The Bioprocessing Summit 2015
The Bioprocessing Summit 2015
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train Platform
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train Platform
 
Explainable AI in Drug Hunting
Explainable AI in Drug HuntingExplainable AI in Drug Hunting
Explainable AI in Drug Hunting
 
Microalgas para la producción de biocombustibles, alimentos y productos químicos
Microalgas para la producción de biocombustibles, alimentos y productos químicosMicroalgas para la producción de biocombustibles, alimentos y productos químicos
Microalgas para la producción de biocombustibles, alimentos y productos químicos
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
 

Mais de National Institute of Biologics

Defining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-productsDefining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-productsNational Institute of Biologics
 
Accelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesAccelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesNational Institute of Biologics
 
Canonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulinsCanonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulinsNational Institute of Biologics
 
Development trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeuticsDevelopment trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeuticsNational Institute of Biologics
 
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...National Institute of Biologics
 
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...National Institute of Biologics
 
Therapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammationTherapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammationNational Institute of Biologics
 
Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...National Institute of Biologics
 
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...National Institute of Biologics
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...National Institute of Biologics
 
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...National Institute of Biologics
 

Mais de National Institute of Biologics (20)

Waters protein therapeutics application proctocols
Waters protein therapeutics application proctocolsWaters protein therapeutics application proctocols
Waters protein therapeutics application proctocols
 
Potential aggregation prone regions in biotherapeutics
Potential aggregation prone regions in biotherapeuticsPotential aggregation prone regions in biotherapeutics
Potential aggregation prone regions in biotherapeutics
 
How the biologics landscape is evolving
How the biologics landscape is evolvingHow the biologics landscape is evolving
How the biologics landscape is evolving
 
Approved m abs_feb_2015
Approved m abs_feb_2015Approved m abs_feb_2015
Approved m abs_feb_2015
 
Translating next generation sequencing to practice
Translating next generation sequencing to practiceTranslating next generation sequencing to practice
Translating next generation sequencing to practice
 
From biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to successFrom biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to success
 
Defining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-productsDefining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-products
 
Accelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesAccelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapies
 
Canonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulinsCanonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulins
 
Canonical correlation
Canonical correlationCanonical correlation
Canonical correlation
 
Development trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeuticsDevelopment trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeutics
 
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
 
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
 
Therapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammationTherapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammation
 
Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...
 
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
 
How dissimilarly similar are biosimilars
How dissimilarly similar are biosimilarsHow dissimilarly similar are biosimilars
How dissimilarly similar are biosimilars
 
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
 
Biosimilars - global scenario and challenges
Biosimilars  - global scenario and challengesBiosimilars  - global scenario and challenges
Biosimilars - global scenario and challenges
 

Último

Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableDipal Arora
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...narwatsonia7
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsGfnyt
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Último (20)

Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 

Speeding up media design in cell culture - a novel high throughput approach for rapid cell culture media development

  • 1. Speeding up media design: a novel high throughput approach for rapid cell culture media development Cell Culture World Congress 2013, Munich, 26 February 2013 Authors: Arnaud Périlleux, Yolande Rouiller, Martin Jordan and Matthieu Stettler Biotech Process Sciences, Upstream Development Group Merck Serono S.A. Vevey, Switzerland
  • 2. Merck Serono at a glance  Merck Serono SA is the largest division of Merck KGaA – Established in January 2007,17’000 employees, EUR 5.9 billion in 2011, headquarter in Darmstadt, Germany – In the United States and Canada, Merck Serono operates under the name of EMD Serono (a separately incorporated affiliate of Merck Serono)  Merck Serono SA process development and production site in Vevey, Switzerland – One of the largest and most technologically advanced biotech centers in the world (4 x 5K and 8 x 15K production capacity) – Production of Rebif® (INF beta-1a) since 1999 – Production of Erbitux® (Cetuximab) since 2011 Merck Serono’s headquarter in Darmstadt (top) and development and production site in Vevey (bottom) 2 Cell Culture World Congress | 26 February 2013
  • 3. Presentation scope  Overview of Merck Serono’s high throughput cell culture methods  Case study #1: High throughput media blending – How to obtain a new high performance medium in one single experiment?  Case study #2: Product quality optimization – How are quality analyses possible with micro-scale culture systems?  Perspectives – Strategies to quickly develop processes with strong quality requirements 3 Cell Culture World Congress | 26 February 2013
  • 4. Merck Serono’s HT cell culture methods Overview Integrated development approach Cell line evaluation Predictive, scalable and comprehensive set of tools High throughput cell culture methods for fed-batch processes assessing 24 to 400+ cultures in parallel Medium development High performance cell lines Media Blending Feed Blending DoE Feed development High performance processes CFD Process development Process validation Quality by Design 4 Cell Culture World Congress | 26 February 2013 Deliver the right product quality
  • 5. Merck Serono’s HT cell culture methods High throughput evaluation of cell lines in fed-batch Transfection and selection A B C D Cloning in static 384 well plate Adaptation in shaking 96DWP A Fed-batch in shaking 96DWP Up to 500 clonal cell lines 0.5 mL 0.5 mL 10 mL Scale up to shake tubes B Fed-batch in shake tubes C 5 Fed-batch in lab-scale bioreactors Cell Culture World Congress | 26 February 2013 30 mL 15 mL Fed-batch in micro-scale bioreactors D 12 cell lines 4 candidate cell lines 3 000 mL
  • 6. Case study #1: High throughput media blending A high-throughput media design approach for high performance mammalian fed-batch cultures Authors: Yolande Rouiller, Arnaud Périlleux, Natacha Collet, Martin Jordan, Matthieu Stettler, Hervé Broly Manuscript accepted, to be published in mAbs
  • 7. Case study #1: High throughput media blending Workflow 47 components 16 media formulations varying 43 out of 47 components Blends automatically mixed in 96DWP Predicted vs. Actual 3 passages prior a 14-days fed-batch Titer (mg/L) Data analysis 376 media blends tested 3000 2000 1000 0 0 2 4 6 8 101214 Elapsed time (days) 7 Cell Culture World Congress | 26 February 2013 Data acquisition
  • 8. Case study #1: High throughput media blending  Protocol – 3 passages prior fed-batch inoculation, an antibody expressing cell line is diluted in each of the 376 blends • Guaranty to obtain a medium suitable for both expansion and fed-batch process Viable Cell Density (x106 cells/mL) Evaluation of 376 media blends – Performance assessment 8 Cell Culture World Congress | 26 February 2013 20 15 10 Titer (mg/L) 2 4 6 8 10 12 14 2 4 6 8 10 12 14 2500 2000 1500 1000 500 • Cell count, Cell viability with a Guava Easycyte • Titer quantification with an Octet Fed-batch process 0 -6 3500 -8Ctrl 1-4 -2 0 3000 Ctrl 2 • Standardized and controlled experimental setup • Guaranty to obtain a medium adapted to the feed system Cell expansion 3 passages 5 – Each of the 376 cultures is diluted individually targeting a specific cell density – On day 2, 4, 7 and 10, a reference proprietary feed is added 25 KQe 0 -8 -6 -4 -2 0 Time (days)
  • 9. Case study #1: High throughput media blending Data analysis opportunities Data analysis using three approaches 1st approach: Excel spreadsheet Ranking of various tested conditions Identification of key media formulations Identification of key components Selection of promising formulations 9 2nd approach: DoE (Design Expert) Design of predicted best formulation List of key components to be further optimized Cell Culture World Congress | 26 February 2013 3rd approach: MVA (Simca P++)
  • 10. Case study #1: High throughput media blending Data analysis with Design of Experiment (DoE) Titer at Day 14 Predicted values  DoE analysis allows – To identify the key formulations (out of the 16) – To design new media formulations  DoE analysis does not allow – To understand why some media are better than others 3000 2000 1000 R2 = 0.88 Adj. R2 = 0.84 Pred. R2 = 0.76 0 0 10 Prediction 1 Prediction 4 Prediction 2 Prediction 5 Predicted Values Prediction 3 Average Prediction PDL F16 F15 F14 F13 F12 F11 F10 F9 F8 F7 F6 F5 10.47 238 3933 10.42 226 3908 10.45 230 3902 5th F4 3960 4th F3 10.43 226 3rd F2 Titer 2nd Cell Culture World Congress | 26 February 2013 IVC 1st 35% 30% 25% 20% 15% 10% 5% 0% F1 % of each formulation in the predicted medium Compositions of best predicted media based on the 16 formulations 1000 2000 3000 Observed values 10.39 224 3885 Average 10.43 228 3910
  • 11. Case study #1: High throughput media blending Data analysis with MultiVariate Analysis (MVA)  MVA analysis allows – To rank the 43 components in terms of influence on performance – To identify the key components that could be interesting for further optimization (in orange and yellow)  MVA analysis does not allow – To have a strong confidence in the conclusions due to the relatively low number of conditions tested compared to the high number of factors evaluated Components with strong influence in MVA Components that correlate by design with key components 11 Cell Culture World Congress | 26 February 2013 Titer Day 14 (mg/L) 0.4 0.3 0.2 0.1 0 -0.1 -0.2 -0.3 L-Serine D-Biotin L-Arginine Thymidine L-Aspartic acid L-Leucine L-Glutamic acid Hypoxanthine Zinc Sulfate myo-Inositol NaH2PO4 L-Histidine Sodium Selenite Putrescine L-Tyrosine Riboflavin Choline Chloride Pyridoxine L-Lysine x HCl L-Phenylalanine L-Isoleucine Calcium Chloride Folic acid Vitamin B12 Thiamine Pluronic Ethanolamine L-Aspargine Cupric sulfate L-Cysteine Niacinamide (B3) Glycine L-Threonine L-Tryptophan L-Proline Magnesium Sulfate L-Alanine L-Methionine Sodium pyruvate Potassium Chloride L-Valine D-Pantothenic acid x 1/2Ca Ferric ammonium citrate Coefficients scaled & centered (components 1 to 3 of PLS model) Influence of increased levels of the tested components in the PLS regression of titers at day 14 Ferric Ammonium Citrate (mg/L)
  • 12. Case study #1: High throughput media blending Scale-up, confirmation and conclusions Reference New medium medium Cell line 1 Cell line 2 Cell line 3  8 media from the ranking approach and 1 from the DoE approach were scaled up in shake tubes  1 medium was selected for scale up in bioreactor and evaluated on several cell lines – The 3 cell lines showed from 30 to 60% titer improvement Titer (mg/L) – data not shown 6000 5000 4000 3000 2000 1000 0  Conclusions 0 2 4 6 8 10 12 14 16 18 Time (days) – Media blending allows in one single experiment to identify new media formulations with high potential for performance improvement – Same approach can be made with feeds – An approach combining medium and feed blending can be designed 12 Cell Culture World Congress | 26 February 2013
  • 13. Case study #2: Product quality optimization using high-throughput cell culture methods
  • 14. Case study #2: Product quality optimization Are quality analyses possible with micro-scale cultures?  Context – Cell culture process development required to optimize a large number of critical quality attributes (CQAs) • Isoforms (deamidation, oxydation, …), glycoforms, (galactosylation, mannosylation, fucosylation, sialylation), product integrity, process impurities – Most of the CQAs are linked to the recombinant cell line, the medium and feeds, and the process (physical parameters) – To ensure a successful process development (e.g. next generation process), it is important that the new process provides a product with the same quality 14 Cell Culture World Congress | 26 February 2013
  • 15. Case study #2: Product quality optimization Are quality analyses possible with micro-scale cultures?  Challenges – High throughput cell culture methods (i.e. 96DWP) provide small amounts of product Fed batch process in 96DWP 400-500 µL 225-1500 µg – Analytical lab should be able to analyze 400+ samples with 5+ analytical methods • Capture, glycan analysis, charge profile, integrity, …  Achievements – A combination of media blending and DoE generated 400 samples of about 400 µL Capture on Phytips® Charge profile iCE280 Glycan analysis CGE-LIF – Samples were captured using Phytips® – Samples were analyzed in 2.5 weeks on 5 analytical methods – 8800 results were generated 15 Cell Culture World Congress | 26 February 2013 Integrity SE-HPLC Caliper NR
  • 16. Case study #2: Product quality optimization Experiment design Factors tested in DoE  Combine media blending and DoE design Zn N-acetylcystein Cu pH  HCl Fe NaCl Se NaButyrate Mn Hydrocortisone Galactose Spermine Ascorbic acid + Retinol + 4-aminobenzoic acid + a-tocopherol Lipids – 5 new Basal Media (BM) mixed to obtain 11 media – 17 factors tested in DoE by addition on day 5 – Standard platform feeding strategy – Analytics performed on day 14 • Biacore • CGE-LIF, iCE280 • Caliper NR, SE HPLC Fucose Uridine ManNAc Additional factors 2ndary feed Main Feed Glucose 0 16 Cell Culture World Congress | 26 February 2013 3 5 7 10 14
  • 17. Case study #2: Product quality optimization Results – After optimization, the confirmation and scale up of a new manufacturing process version was performed 17 Cell Culture World Congress | 26 February 2013 Model: R2 = 74.9% / R2 adj. = 71.2% BM4 • to select 4 factors and 2 media for further optimization 32 DoE conditions Mix1 • to fix the levels of 4 factors 1.0 0.8 0.6 0.4 0.2 0.0 -0.2 -0.4 -0.6 Spermine – Models allow Std. Coef. (Cluster 4) – For most of the CQAs, at least some conditions were able to match the TPP Control (n=4) BM3  Conclusions Mix5 10 Mix4 – Lists of key media and factors were established from models 15 NaCl – Models were defined 20 All data BM1 BM2 BM3 BM4 BM5 Mix1 Mix2 Mix3 Mix4 Mix5 Mix6 BM1 BM2 BM3 BM4 BM5 – Distribution of results was compared to Target Product Profile (TPP) 25 Cu  For each CQA Charge Profile Cluster 4 (%) 30
  • 18. HT cell culture – Speeding up media design Conclusions  High throughput tools are now available for cell culture, but also for purification and analytics  Designing the right experiments allows to get the maximum of these tools and to reduce development timelines  Their use has been mainly directed to media design, but their application to feed design could even provide more interesting results 18 Cell Culture World Congress | 26 February 2013
  • 19. Acknowledgements  Biotech Process Sciences (BPS), Merck Serono SA Vevey, Switzerland – Hervé Broly - Head of BPS – Upstream Development Group – Flavie Robert - Head of Analytical Group 19 Cell Culture World Congress | 26 February 2013
  • 20. Questions 20 Cell Culture World Congress | 26 February 2013